Z A.
Very disappointing response to a…
Very disappointing response to a straightforward scientific question. I was considering purchasing Blueprint’s £57 SFC Facial Serum and asked whether it contained the 1% SFC concentration used in the clinical research referenced to support its benefits. I was not asking for their formulation, manufacturing process or trade secrets. I simply wanted to establish whether the product contained a concentration comparable to the one shown to be effective in the cited study. After waiting a week for the team to investigate, I was told that the concentration was “proprietary”. My second question, whether the finished product had undergone clinical efficacy testing, was also left unanswered. Instead, I received information about safety, stability and compatibility testing, none of which demonstrates that the product delivers its advertised benefits. I find this particularly disappointing from a brand built around scientific rigour, transparency and evidence-based interventions. If a company uses clinical research to promote an expensive skincare product, I think customers are entitled to ask whether the formulation being sold is comparable to the one studied. I wasn’t expecting disclosure of commercial secrets. I was expecting a meaningful, evidence-based answer. Unfortunately, the response has undermined my confidence in the product and the brand’s commitment to scientific transparency.

